AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure. AnaCardio was founded based on ground-breaking research from Karolinska Institutet showing improved contractility of the heart muscle through a unique and differentiated mechanism. Its lead program AC01 is planned to enter phase 2 clinical development in heart failure patients in 2022. You can find more information about AnaCardio at www.anacardio.com.
View Top Employees from AnaCardioWebsite | http://www.anacardio.com |
Employees | 17 (2 on RocketReach) |
Address | Nanna Svartz väg 4, Innomedicum, Solna, Stockholm County 171 65, SE |
Industry | Pharmaceutical Manufacturing |
Looking for a particular AnaCardio employee's phone or email?
2 people are employed at AnaCardio.
AnaCardio is based in Solna, Stockholm County.